Project Extension for Community Healthcare Outcomes (ECHO) Diabetes Trial Improves Outcomes for Medically Underserved People
Authors' conclusion
The ECHO model demonstrates promise for reducing health disparities in diabetes and contributes to our understanding of program benefits beyond the provider level.
Study context
- Population
- Medically underserved people with T1D or T2D at 20 federally qualified health centers across California and Florida582 in patient-level cohort
- Participants
- 32,796 participants
- Comparison
- ECHO Diabetes program, before vs after intervention
Methodological detailsrandomized, phased-in intervention entry, 20 federally qualified health centers (FQHCs)
- Randomized, phased-in intervention entry
- 20 FQHCs
Primary result
As reported in the abstract
Spoke level: proportion with HbA1c >9%
P = 0.033
Further findings
Patient level: CGM use · statistically significant increase
P < 0.0001
Patient level: pump use · statistically significant increase
P < 0.001
Original publication
Project ECHO Diabetes Trial Improves Outcomes for Medically Underserved People. Diabetes Care. Published 17 December 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →